Abstract
Protein kinases form one of the largest superfamily of enzymes that play pivotal roles in controlling almost every signaling pathway (1). Deregulated kinase activity thus leads to multiple diseases, including various forms of cancer (2), inflammatory and autoimmune diseases (3), neurodegenerative diseases (4,5), diabetes (6), and HIV infection (7). Signaling networks regulated by kinases are complex and highly interconnected. Additionally, many kinases display overlapping substrate specificities in vitro and can functionally compensate for each other in single gene knockout experiments (8,9). Therefore, unraveling of these pathways to dissect the role of any particular kinase (normal or oncogenic) has remained one of the major challenges ever since the first kinase was purified. Ideally, if the substrate of each kinase could be identified in a cell, it would provide a baseline for understanding the complex cellular functions and consequently also provide a blueprint for novel targets for drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hunter, T. (2000) Signaling-2000 and Beyond. Cell 100, 113–127.
Sawyers, C. L. (2002) Rational therapeutic intervention in cancer: kinases as drug targets. Curr. Opin. Genet. Dev. 12, 111–115.
Lewis, A. J. and Manning, A. M. (1999) New targets for anti-inflammatory drugs. Curr. Opin. Chem. Biol. 3, 489–494.
Maccioni, R. B., Munoz, J. P., and Barbeito, L. (2001) The molecular bases of Alzheimer’s disease and other neurodegenerative disorders. Arch. Med. Res. 32, 367–381.
Wagey, R. T. and Krieger, C. (1998) Abnormalities of protein kinases in neurode-generative diseases. Prog. Drug Res. 51, 133–183
Jiang, G. and Zhang, B. B. (2002) Pi 3-kinase and its up-and down-stream modulators as potential targets for the treatment of type II diabetes. Front. Biosci. 7, d903–d907.
Arasteh, K. and Hannah, A. (2000) The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi’s sarcoma. Oncologist 5(Suppl. 1), 28–31.
Ghaffari, S., Wu, H., Gerlach, M., Han, Y., Lodish, H. F., and Daley, G. Q. (1999) BCR-ABL and v-Src tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells. Proc. Natl. Acad. Sci. USA 96, 13,186–13,190.
Ihle, J. N. (2000) The challenges of translating knockout phenotypes into gene function. Cell 102, 31–134.
Songyang, Z. and Cantley, L. C. (1998) The use of peptide library for the determination of kinase peptide substrates. Methods Mol. Biol. 87, 87–98.
Fukunaga, R. and Hunter, T. (1997) MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16, 1921–1933.
Lock, P., Abram, C. L., Gibson, T., and Courtneidge, S. A. (1998) A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate. EMBO J. 17, 4346–4357.
Stukenberg, P. T., Lustig, K. D., McGarry, T. J., King, R. W., Kuang, J., and Kirschner, M. W. (1997) Systematic identification of mitotic phosphoproteins. Curr. Biol. 7, 338–348.
Deng, S. J., Liu, W., Simmons, C. A., Moore, J. T., and Tian, G. (2001) Identifying substrates for endothelium-specific Tie-2 receptor tyrosine kinase from phage-displayed peptide libraries for high throughput screening. Comb. Chem. High Throughput Screen 4, 525–533.
Zhu, H., Klemic, J. F., Chang, S., Bertone, P., Casamayor, A., Klemic, K. G., et al. (2000) Analysis of yeast protein kinases using protein chips. Nat. Genet. 26, 283–289.
Zhu, H., Bilgin, M., Bangham, R., Hall, D., Casamayor, A., Bertone, P., et al. (2001) Global analysis of protein activities using proteome chips. Science 293, 2101–2105.
Pawson, T. and Nash, P. (2000) Protein-protein interactions define specificity in signal transduction. Genes Dev. 14, 1027–1047.
Perez, O. D. and Nolan, G. P. (2002) Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat. Biotechnol. 20, 155–162.
Neet, K. and Hunter, T. (1995) The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src. Mol. Cell Biol. 15, 4908–4920.
Wu, L. W., Mayo, L. D., Dunbar, J. D., Kessler, K. M., Baerwald, M. R., Jaffe, E. A., et al. (2000) Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J. Biol. Chem. 275, 5096–5103.
Lewis, T. S., Hunt, J. B., Aveline, L. D., Jonscher, K. R., Louie, D. F., Yeh, J. M., et al. (2000) Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. Mol. Cell 6, 1343–1354.
Yoshimura, Y., Shinkawa, T., Taoka, M., Kobayashi, K., Isobe, T., and Yamauchi, T. (2002) Identification of protein substrates of Ca(2+)/calmodulin-dependent protein kinase II in the postsynaptic density by protein sequencing and mass spectrometry. Biochem. Biophys. Res. Commun. 290, 948–954.
Knebel, A., Morrice, N., and Cohen, P. (2001) A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO. J. 20, 4360–4369.
Zhou, S. and Cantley, L. C. (1995) Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem. Sci. 20, 470–475.
Shah, K., Liu, Y., Deirmengian, C., and Shokat, K. M. (1997) Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. Proc. Natl. Acad. Sci. USA 94, 3565–3570.
Liu, Y., Shah, K., Yang, F., Witucki, L., and Shokat, K. M. (1998) Engineering Src family protein kinases with unnatural nucleotide specificity. Chem. Biol. 5, 91–101.
Liu, Y., Shah, K., Yang, F., Witucki, L., and Shokat, K. M. (1998) A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src. Bioorg. Med. Chem. 6, 1219–1226.
Liu, Y., Bishop, A., Witucki, L., Kraybill, B., Shimizu, E., Tsien, J., et al. (1999) Structural basis for selective inhibition of Src family kinases by PP1. Chem. Biol. 6, 671–678.
Adams, J., Huang, P., and Patrick, D. (2002) A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis. Curr. Opin. Chem. Biol. 6, 486–492.
Weiss, E. L., Bishop, A. C., Shokat, K. M., and Drubin, D. G. (2000) Chemical genetic analysis of the budding-yeast p21-activated kinase Cla4p. Nat. Cell Biol. 2, 677–685.
Habelhah, H., Shah, K., Huang, L., Burlingame, A. L., Shokat, K. M., and Ronai, Z. (2001) Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J. Biol. Chem. 276, 18,090–18,095.
Witucki, L. A., Huang, X., Shah, K., Liu, Y., Kyin, S., Eck, M. J., et al. (2002) Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phospho-acceptor specificity of the wild-type enzyme. Chem. Biol. 9, 25–33.
Polson, A. G., Huang, L., Lukac, D. M., Blethrow, J. D., Morgan, D. O., Burlin-game, A. L., et al. (2001) Kaposi’s sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J. Virol. 75, 3175–3184.
Shah, K. and Shokat, K. M. (2002) A chemical genetic screen for direct v-Src substrates reveals ordered assembly of a retrograde signaling pathway. Chem. Biol. 9, 35–47.
Scott, M. P. and Miller, W. T. (2000) A peptide model system for processive phosphorylation by Src family kinases. Biochemistry 39, 14,531–14,537.
Kraybill, B. C., Elkin, L. L., Blethrow, J. D., Morgan, D. O., and Shokat, K. M. (2002) Inhibitor Scaffolds as New Allele Specific Kinase Substrates. J. Am. Chem. Soc. 124, 12,118–12,128.
Bishop, A. C., Shah, K., Liu, Y., Witucki, L., Kung, C., and Shokat, K. M. (1998) Design of allele-specific inhibitors to probe protein kinase signaling. Curr. Biol. 8, 257–266.
Bishop, A. C., Buzko, O., and Shokat, K. M. (2001) Magic bullets for protein kinases. Trends Cell Biol. 11, 167–172.
Bishop, A. C., Ubersax, J. A., Petsch, D. T., Matheos, D. P., Gray, N. S., Blethrow, J., et al. (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407, 395–401.
Carroll, A. S., Bishop, A. C., DeRisi, J. L., Shokat, K. M., and O’Shea, E. K. (2001) Chemical inhibition of the Pho85 cyclin-dependent kinase reveals a role in the environmental stress response. Proc. Natl. Acad. Sci. USA 98, 12,578–12,583.
Yang, F., Liu, Y., Bixby, S. D., Friedman, J. D., and Shokat, K. M. (1999) Highly efficient green fluorescent protein-based kinase substrates. Anal. Biochem. 266, 167–173.
Buzko, O. V. and Shokat, K. M. (2002) A Kinase Sequence database∶sequence alignments and family assignment. Bioinformatics 18, 1274–1275.
Polte, T. R. and Hanks, S. K. (1997) Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130(Cas)) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs. J. Biol. Chem. 272, 5501–5509.
Hecht, S. M. and Kozarich, J. W. (1973) A chemical synthesis of adenosine 5′-(gamma-32P)triphosphate. Biochim. Biophys. Acta 331, 307–309.
DeClue, J. E. and Martin, G. S. (1989) Linker insertion-deletion mutagenesis of the v-Src gene: isolation of host-and temperature-dependent mutants. J. Virol. 63, 542–554.
Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392–8396.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Shah, K., Shokat, K.M. (2003). A Chemical Genetic Approach for the Identification of Direct Substrates of Protein Kinases. In: Newton, A.C. (eds) Protein Kinase C Protocols. Methods in Molecular Biology™, vol 233. Humana Press. https://doi.org/10.1385/1-59259-397-6:253
Download citation
DOI: https://doi.org/10.1385/1-59259-397-6:253
Publisher Name: Humana Press
Print ISBN: 978-1-58829-068-7
Online ISBN: 978-1-59259-397-2
eBook Packages: Springer Protocols